Review of the Australian New Zealand Clinical Trials Registry
The Commonwealth Department of Health has recently commissioned Aspex Consulting to undertake a review of the Australian New Zealand Clinical Trials Registry (ANZCTR).
The ANZCTR is a critical component of national clinical trial infrastructure and part of a worldwide approach to make information about all clinical trials available to the public. Trial registration through ANZCTR has the potential to improve research transparency, facilitate trial participation, avoid research duplication, identify research gaps and promote collaboration.
The review will assess current performance, appropriateness and value for money of the ANZCTR, including current users and uses; the extent that current services are meeting the needs of stakeholders; and alignment to contemporary international and domestic best practice for clinical trial registries. Based on these findings, the review will consider options for a potential next generation Australian clinical trial registry.